• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
Nairametrics
No Result
View All Result
Home Companies Company News

Niemeth to raise N5 billion from right issue, private placement for expansion

Chris Ugwu by Chris Ugwu
August 2, 2022
in Company News
Niemeth to raise N5 billion from right issue, private placement for expansion
Share on FacebookShare on TwitterShare on Linkedin

Neimeth International Pharmaceuticals Plc has disclosed a plan to raise more capital through right issue and private placement to be used for a two-pronged expansion plan, namely the construction of a new plant in Anambra State and a facility upgrade of the Oregun plant.

The company planned to raise about N5 billion through right issues and private placement.

The Rights Issue which will commence on August 3, 2022, will be used to raise the sum of N3,679,618,625 at the cost of N1.55k per 50 Kobo share.

RelatedStories

Neimeth International Pharmaceuticals reports loss of N406 million for the year 2022

Neimeth stock gains over 45% after shareholders authorize N20bn capital raise, other plans at AGM 

June 26, 2025
Neimeth International Pharmaceuticals reports loss of N406 million for the year 2022

Neimeth appoints Christopher Oshiafi as chairman

June 24, 2024

To carry out the Rights Issue, the Company in March 2022, created 2,373,947,500 additional Ordinary Shares which will be allotted at the rate of five new shares for every four shares currently held in the company to existing Shareholders.

What the company is saying

Pharm. Matthew Obi Azoji, Managing Director/CEO, Neimeth speaking to journalists in Lagos disclosed that the Private Placement will commence immediately after the Rights Issue has closed.

  • “The company is offering 628,753,036 Ordinary Shares to would-be investors at the price of N2.10. This is expected to generate N1, 320,381.375.60 through this channel.
  • “The money is being raised to fund our strategic expansion plans. Last year, at the 62nd Annual General Meeting of the company, our shareholders approved a two-pronged expansion plan, namely the construction of a new plant in Anambra State and a facility upgrade of the Oregun plant.
  • “The new plant will be a multi-product facility that will be tailored to comply with the World Health Organization (WHO) current standards of Good Manufacturing Practice (cGMP) at Amawbia in Anambra State.
  • “Part of the funds will also be used to support the company’s strategic plan of maintaining a sustainable capital structure, leverage the company’s balance sheet, reduce cost of borrowing or finance costs and fund working capital.
  • “The Oregun factory upgrade is already close to completion with funds from the Bank of Industry (BOI) and own resources. On completion, the Oregun plant alone will add additional 300 per cent to the Company’s production capacity especially with liquid preparations.
  • “These projects will not only sustain the current upbeat performance of the company but will give us a quantum leap into the league of leading global healthcare commodities producers,” he said.

Azoji noted that the company is pioneering research and development into African home-grown solutions to various diseases. Already; it has many therapeutic formulations that will provide solutions to various human and animal diseases.

  • “Neimeth is also partnering with overseas pharmaceutical companies to formulate medicaments for various common ailments on the continent. Currently; it has about 13 different human pharmaceutical lines undergoing registration while about nine veterinary products are underway. About 25 other human pharmaceutical products are scheduled to be submitted to the National Agency for Food and Drug Administration and Control (NAFDAC) for registration soon.
  • “Most of these products are expected to be introduced into the market in the current business year, thus expanding the company’s product portfolio,” he added.

Follow us for Breaking News and Market Intelligence.
Tags: Neimeth International Pharmaceuticals PlcPharm. Matthew Obi Azoji
Chris Ugwu

Chris Ugwu

Chris is a Senior Financial Analyst at Nairametrics Advocates Limited with over a decade stint in active journalism and public relations practice.

Related Posts

Neimeth International Pharmaceuticals reports loss of N406 million for the year 2022
Equities

Neimeth stock gains over 45% after shareholders authorize N20bn capital raise, other plans at AGM 

June 26, 2025
Neimeth International Pharmaceuticals reports loss of N406 million for the year 2022
Appointments

Neimeth appoints Christopher Oshiafi as chairman

June 24, 2024
Bryant (ABC) Orjiako
Company News

Neimeth faces profitability challenges amid high cost of forex, inflation pressure

May 20, 2023
Neimeth says it got 'no objection' from SEC for allotment of shares
Company News

Neimeth says it got ‘no objection’ from SEC for allotment of shares

February 9, 2023
Commercial paper issuance
Corporate deals

Three Nigerian corporates brave economic uncertainty, plan to raise N58.6 billion via right issue

July 30, 2022
Company Results

Neimeth International Plc to raise N5billlion additional capital through rights issue and private placement

June 3, 2021
Next Post
NGX closes positive as investors gain N272 billion

Top stockbroking firms in Nigeria trade N59.8 billion worth of stocks in July 2022

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Emple
nlng
first bank








DUNS

Recent News

  • 15 things you don’t need to start a business in Nigeria 
  • NNPC, Akwa Ibom, GACN sign $3.5 billion gas agreement
  • Key policies that shaped Nigeria’s tech industry under Buhari’s 8-year rule 

Follow us on social media:

Recent News

Small Business

15 things you don’t need to start a business in Nigeria 

July 15, 2025
NNPC, Akwa Ibom, GACN sign $3.5 billion gas agreement

NNPC, Akwa Ibom, GACN sign $3.5 billion gas agreement

July 15, 2025
  • iOS App
  • Android App
  • Contact Us
  • Home
  • Markets
  • Sectors
  • Economy
  • Business News
  • Financial Literacy
  • Disclaimer
  • Ads Disclaimer
  • Copyright Infringement

© 2025 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Economy
    • Nairalytics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Business News
    • Budget
    • Public Debt
    • Funds Management
    • Tax
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
    • Research Analysis
  • Recapitalization
    • Access Holdings Offer
    • Fidelity Bank Offer
    • GTCO Offer
    • Zenith Bank Offer
  • Login
  • Sign Up

© 2025 Nairametrics